| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 5e-13 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 1e-09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |